Androgen receptor: Structural domains and functional dynamics after ligand-receptor interaction

Annals of the New York Academy of Sciences

Volumn 949, Issue , 2001, Pages 44-57

  Roy, Arun K ^a   Tyagi, Rakesh K ^a   Song, Chung S ^a,b   Lavrovsky, Yan ^a   Ahn, Soon C ^a   Oh, Tae Sung ^a   Chatterjee, Bandana ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Androgen receptor; Chlozolinate; Endocrine disrupters; Green fluorescent protein; Procymidone; Receptor recycling; SARM; Vinclozolin

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CYTOPLASM PROTEIN; HORMONE RECEPTOR AFFECTING AGENT; LIGAND; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADRENAL GLAND; CONFERENCE PAPER; DISSOCIATION; GENE EXPRESSION; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; GENOME; HORMONE RELEASE; HUMAN; INTRACELLULAR TRANSPORT; LIGAND BINDING; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REPRODUCTION; TESTIS; TRANSACTIVATION;

EID: 0035680408     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb04001.x     Document Type: Conference Paper

References (32)

1. Molecular action of androgen in the normal and neoplastic prostate
2. Androgen receptor locus on the human X chromosome: Regional localization to Xq11-12 and description of a DNA polymorphism
3. Structural organization of the human androgen receptor gene
4. Characterization of the human androgen receptor transcription unit
5. Androgen receptors: Structures, mutations, antibodies, and cellular dynamics
6. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation
7. Domain functions of the androgen receptor
8. Functional domains of the human androgen receptor
9. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
10. Analysis of exon 1 mutations in the androgen receptor gene
11. Androgen receptor defects: Historical, clinical, and molecular perspectives
12. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer
13. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
14. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
15. Nuclear receptor coregulators: Cellular and molecular biology
16. Strategies for transcriptional activation by steroid/nuclear receptors
17. Determinants of target gene specificity for steroid/thyroid hormone receptors
18. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
19. The nuclear receptor ligand-binding domain: Structure and function
20. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations
21. Regulation of androgen action
22. Dynamics of intracellular, movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells
23. Regulation of steroid receptor subcellular trafficking
24. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor
25. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1
26. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily
27. Inhibition of nuclear hormone receptor activity by calreticulin
28. Control of tumor progression by maintenance of apoptosis
29. Calreticulin is a receptor for nuclear export
30. An updated review of environmental estrogen and androgen mimics and antagonists
31. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist
32. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide